Classification
- Anatomical main groupRRespiratory system
- Therapeutic subgroupR03
- Pharmacological subgroupR03B
- Chemical subgroupR03BB
- Chemical substanceR03BB01Ipratropium bromide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 46 registrations
- Aa-Ipravent250 MCG / ML · Solution · Aa Pharma INC
- Atrovent HFA20 MCG / ACT · Aerosol (Metered-Dose) · Boehringer Ingelheim (Canada) LTD Ltee
- Ipravent42 MCG / ACT · Solution · Aa Pharma INC
- Jamp Ipratropium HFA20 MCG / ACT · Aerosol (Metered-Dose) · Jamp Pharma Corporation
Netherlands
CBG-MEB · 23 registrations
At a glance
- ATC code
- R03BB01
- ATC group
- Respiratory system
- Registers
- 8
- Historical lists
- 2
- Registrations
- 141
- With their own page
- 96
- Companies
- 56
All medicines with Ipratropium bromide
Human medicines from every register that match Ipratropium bromide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
162 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ipratropium Bromide | United States | 0.02% | solution | Marketed | Zennova |
| Ipratropium Bromide | United States | 0.021MG/INH | aerosol, metered | Marketed | Armstrong Pharms |
| Ipratropium Bromide | United States | 0.021MG/SPRAY, 0.042MG/SPRAY | spray, metered | Marketed | Apotex INC |
| Ipratropium Bromide and Salbutamol Sulphate Inhalation SolutionCombination | Canada | 0.5 MG / 2.5 ML + 2.5 MG / 2.5 ML | Solution | Marketed | Juno Pharma Canada INC. |
| Albuterol Sulfate; Ipratropium BromideCombination | United States | 0.5MG; 0.017% | solution | Marketed | Nephron |
| Albuterol Sulfate and Ipratropium BromideCombination | United States | 0.083% BASE; 0.017% | solution | Marketed | Teva Pharms |
| Atrovent HFA | United States | 0.021MG/INH | aerosol, metered | Marketed | Boehringer Ingelheim |
| PMS-Ipratropium | Canada | 21 MCG / ACT | Solution | Marketed | Pharmascience INC |
| PMS-Ipratropium | Canada | 125 MCG / ML | Solution | Marketed | Pharmascience INC |
| PMS-Ipratropium | Canada | 250 MCG / ML | Solution | Marketed | Pharmascience INC |
| PMS-Ipratropium | Canada | 250 MCG / ML | Solution | Marketed | Pharmascience INC |
| Atrovent | United States | 0.021MG/SPRAY, 0.042MG/SPRAY | spray, metered | Not marketed | Boehringer Ingelheim |
| Atrovent | United States | 0.02% | solution | Not marketed | Boehringer Ingelheim |
| Atrovent | United States | 0.018MG/INH | aerosol, metered | Not marketed | Boehringer Ingelheim |
| Jamp Ipratropium HFA | Canada | 20 MCG / ACT | Aerosol (Metered-Dose) | Marketed | Jamp Pharma Corporation |
| PMS-Ipratropium | Canada | 250 MCG / ML | Solution | Not marketed | Pharmascience INC |
| Teva-Ipratropium Sterinebs | Canada | 250 MCG / ML | Solution | Marketed | Teva Canada Limited |
| Ipratropiumbromide Aurobindo 250 microgram/ml verneveloplossing, verneveloplossing | Netherlands | Verneveloplossing | Authorised | Aurobindo Pharma B.V. | |
| Ipratropiumbromide Sandoz 20 microgram/dosis, aërosol, oplossing | Netherlands | Aërosol, oplossing | Authorised | Sandoz B.V. | |
| Ipratropiumbromide 20 microgram/dosis Vincion, aërosol, oplossing | Netherlands | Aërosol, oplossing | Authorised | Vincion BV | |
| Ipratropiumbromide 1A Pharma 20 microgram/dosis, aërosol, oplossing | Netherlands | Aërosol, oplossing | Authorised | 1A Pharma GmbH | |
| Ipratropium Viatris | New Zealand | Nebuliser soln 250 mcg per ml, 2 ml ampoule | Funded | ||
| Ipratropium Viatris | New Zealand | Nebuliser soln, 250 mcg per ml, 2 ml ampoule | Funded | ||
| Ipratropiumbromide/Salbutamol Abdi 0,5 mg/2,5 mg per 2,5 ml verneveloplossingCombination | Netherlands | Verneveloplossing | Authorised | Abdi Farma GmbH | |
| Ipratropiumbromide/Salbutamol Sandoz 0,5/2,5 mg per 2,5 ml, verneveloplossingCombination | Netherlands | Verneveloplossing | Authorised | Sandoz B.V. |